New research on the use of novel oral anticoagulants for atrial fibrillation patients and statins for diabetes patients from the American College of Cardiology's National Cardiovascular Data Registry will be presented at the American Heart Association meeting in Orlando this weekend. Three abstracts from the PINNACLE Registry, which captures data on coronary artery disease, hypertension, heart failure and atrial fibrillation, are now available.
- Gender Differences in Use of Anti-Coagulant For Atrial Fibrillation: A Report From the NCDR
EMBARGOED: Sunday, Nov. 8, 4:45 p.m. EST
- Frequency and Practice Level Variation in Statin Use Among Patients With Diabetes: Insights From the NCDR PINNACLE Registry
EMBARGOED: Monday, Nov. 9, 9:00 a.m. EST
- The Introduction of Novel Oral Anticoagulants Has Improved Overall Oral Anticoagulation Rates in Atrial Fibrillation: Insights From the NCDR PINNACLE Registry
EMBARGOED: Monday, Nov. 9, 6:00 p.m. EST
To view the abstracts under embargo or speak to a researcher, contact Nicole Napoli at email@example.com or 202-669-1465.
The American College of Cardiology is a 49,000-member medical society that is the professional home for the entire cardiovascular care team. The mission of the College is to transform cardiovascular care and to improve heart health. The ACC leads in the formation of health policy, standards and guidelines. The College operates national registries to measure and improve care, provides professional medical education, disseminates cardiovascular research and bestows credentials upon cardiovascular specialists who meet stringent qualifications. For more information, visit acc.org.